Stock Scorecard
Stock Summary for KalVista Pharmaceuticals Inc (KALV) - $26.97 as of 6/2/2026 6:25:05 PM EST
Total Score
8 out of 30
Safety Score
35 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for KALV
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for KALV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for KALV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for KALV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for KALV (35 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for KALV
Financial Details for KALV
Company Overview |
|
|---|---|
| Ticker | KALV |
| Company Name | KalVista Pharmaceuticals Inc |
| Country | USA |
| Description | KalVista Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, discovers, develops, and markets small-molecule protease inhibitors for illnesses with unmet needs. The company is headquartered in Cambridge, Massachusetts. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 4/30/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 26.97 |
| Price 4 Years Ago | 6.76 |
| Last Day Price Updated | 6/2/2026 6:25:05 PM EST |
| Last Day Volume | 2,605,771 |
| Average Daily Volume | 5,677,809 |
| 52-Week High | 26.98 |
| 52-Week Low | 9.83 |
| Last Price to 52 Week Low | 174.36% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 81.21 |
| Sector PE | 59.49 |
| 5-Year Average PE | -6.16 |
| Free Cash Flow Ratio | 6.26 |
| Industry Free Cash Flow Ratio | 29.42 |
| Sector Free Cash Flow Ratio | 25.42 |
| Current Ratio Most Recent Quarter | 5.58 |
| Total Cash Per Share | 4.31 |
| Book Value Per Share Most Recent Quarter | -0.05 |
| Price to Book Ratio | 49.03 |
| Industry Price to Book Ratio | 11.37 |
| Sector Price to Book Ratio | 9.57 |
| Price to Sales Ratio Twelve Trailing Months | 12.53 |
| Industry Price to Sales Ratio Twelve Trailing Months | 9.76 |
| Sector Price to Sales Ratio Twelve Trailing Months | 9.36 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 53,241,000 |
| Market Capitalization | 1,435,909,770 |
| Institutional Ownership | 131.36% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 10.44% |
| Reported EPS 12 Trailing Months | -3.94 |
| Reported EPS Past Year | -1.53 |
| Reported EPS Prior Year | -3.69 |
| Net Income Twelve Trailing Months | -112,442,000 |
| Net Income Past Year | -164,286,000 |
| Net Income Prior Year | -183,444,000 |
| Quarterly Revenue Growth YOY | 30.70% |
| 5-Year Revenue Growth | 42.14% |
| Operating Margin Twelve Trailing Months | -57.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 229,342,000 |
| Total Cash Past Year | 229,342,000 |
| Total Cash Prior Year | 98,644,000 |
| Net Cash Position Most Recent Quarter | 90,314,000 |
| Net Cash Position Past Year | 90,115,000 |
| Long Term Debt Past Year | 139,227,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 139,028,000 |
| Equity to Debt Ratio Past Year | -0.02 |
| Equity to Debt Ratio Most Recent Quarter | -0.02 |
| Total Stockholder Equity Past Year | -2,711,000 |
| Total Stockholder Equity Prior Year | 95,391,000 |
| Total Stockholder Equity Most Recent Quarter | -2,711,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -38,818,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.73 |
| Free Cash Flow Past Year | -83,328,000 |
| Free Cash Flow Prior Year | -153,341,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.29 |
| MACD Signal | 1.57 |
| 20-Day Bollinger Lower Band | 10.55 |
| 20-Day Bollinger Middle Band | 19.54 |
| 20-Day Bollinger Upper Band | 28.52 |
| Beta | -0.12 |
| RSI | 75.19 |
| 50-Day SMA | 15.65 |
| 150-Day SMA | 12.69 |
| 200-Day SMA | 11.73 |
System |
|
| Modified | 6/2/2026 2:08:01 AM EST |